Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 15 Nov 2024

Advancing EGFR mutation subtypes prediction in NSCLC by combining 3D pretrained ConvNeXt, radiomics, and clinical features

in Thoracic Oncology

Peng Hao
Yinghong Yu
Chan-Tao Huang
Fang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1464555

1,439 views

Case Report

Published on 13 Nov 2024

Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors

in Thoracic Oncology

Roberto Rosenfeld
Silvia Riondino
Giusy Parisi
Giovanni Maria Iannantuono
Rexhina Ajdhoni
Francesco Torino
Sabrina Mariotti
Mario Roselli

Frontiers in Oncology

doi 10.3389/fonc.2024.1417776

1,009 views
1 citation

Case Report

Published on 13 Nov 2024

Case report: The effect of induction targeted therapies in stage III driver mutants non-small cell lung cancer

in Thoracic Oncology

Waleed Kian
Belal Krayim
Betsy Giles
Nasim A. Elkiaan
Amjad Idris
Daniel Fink
Nir Peled
Laila C. Roisman

Frontiers in Oncology

doi 10.3389/fonc.2024.1286116

1,818 views
1 citation

Case Report

Published on 13 Nov 2024

When multiple primary lung cancers express the same rare mutation: a case report

in Thoracic Oncology

Yaqing Han
Yandong Geng
Qian Sui
Yanjie Liu
Shaonan Xie
Maogang Gao
Qingyi Liu
Guangjie Liu
Shize Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1475193

927 views

Original Research

Published on 08 Nov 2024

Development and validation of a nomogram for predicting histologic subtypes of subpleural non-small cell lung cancer using ultrasound parameters and clinical data

in Thoracic Oncology

Feng Mao
Mengjun Shen
Yi Zhang
Hongwei Chen
Yang Cong
Huiming Zhu
Chunhong Tang
Shengmin Zhang
Yin Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1477450

931 views

Review

Published on 08 Nov 2024

Research progress on the role of bypass activation mechanisms in resistance to tyrosine kinase inhibitors in non-small cell lung cancer

in Thoracic Oncology

Ziyang Jiang
Zhihan Gu
Xiaomin Yu
Tao Cheng
Bofu Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1447678

2,403 views
3 citations

Case Report

Published on 07 Nov 2024

Case report: Pulmonary Ewing sarcoma disguised as non-small cell lung cancer

in Thoracic Oncology

Mary E. Carter
Alessia Benegiamo-Chilla
Linus D. Kloker
Nikolas Paulsen
Vlatko Potkrajcic
Frank Paulsen
Attila Nemeth
Volker Steger
Martin Schulze
Saskia Biskup

Frontiers in Oncology

doi 10.3389/fonc.2024.1449119

1,741 views

Systematic Review

Published on 07 Nov 2024

Efficacy and safety of Toliparibumab for the treatment of non-small cell lung cancer: a systematic review and meta-analysis

in Thoracic Oncology

Yihao Liu
Liangyu Yang
Zhixuan Duan
Qian Cheng
Minghui Liu
HongBing Zhang
HongLin Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1444312

1,644 views
1 citation

Case Report

Published on 07 Nov 2024

Case report: Combination therapy of envafolimab with endostar for advanced non-small cell lung cancer with low PD-L1 expression

in Thoracic Oncology

Shuo Wu
Changhong Dong
Chenxi Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1437260

1,202 views

Original Research

Published on 04 Nov 2024

The causal nexus between diverse smoking statuses, potential therapeutic targets, and NSCLC: insights from Mendelian randomization and mediation analysis

in Thoracic Oncology

Zhenghua Cao
Shengkun Zhao
Tong Wu
Huan Ding
Zhiyu Tian
Feng Sun
Zhuo Feng

Frontiers in Oncology

doi 10.3389/fonc.2024.1438851

1,565 views
1 citation

Editorial

Published on 04 Nov 2024

Editorial: Innovative strategies and new insights for the treatment of stage III non-small cell lung cancer

in Thoracic Oncology

Francesco Cortiula
Aakash Desai
Jessica Menis
Andrea R. Filippi

Frontiers in Oncology

doi 10.3389/fonc.2024.1503613

874 views

Original Research

Published on 04 Nov 2024

Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study

in Thoracic Oncology

Anna Tanaka
Shuhei Teranishi
Yukihito Kajita
Tomofumi Hirose
Ayami Kaneko
Yu Sairenji
Hidetoshi Kawashima
Kentaro Yumoto
Toshinori Tsukahara
Kenji Miura

Frontiers in Oncology

doi 10.3389/fonc.2024.1400277

1,795 views

Mini Review

Published on 01 Nov 2024

Exercise’s impact on lung cancer molecular mechanisms: a current overview

in Thoracic Oncology

Annamaria Mancini
Francesca Maria Orlandella
Daniela Vitucci
Neila Luciano
Andreina Alfieri
Stefania Orrù
Giuliana Salvatore
Pasqualina Buono

Frontiers in Oncology

doi 10.3389/fonc.2024.1479454

2,040 views

Case Report

Published on 01 Nov 2024

Therapeutic strategies to overcome ALK-fusion and BRAF-mutation as acquired resistance mechanism in EGFR-mutated non-small cell lung cancer: two case reports

in Thoracic Oncology

Yuan Zeng
Qiang Zeng
Bin Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1390523

1,547 views
1 citation

Case Report

Published on 31 Oct 2024

Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer—a case series of divergent results from a large reference laboratory

in Thoracic Oncology

Kyle C. Strickland
Mary K. Nesline
Rebecca A. Previs
Heidi Ko
Maureen Cooper
Jennifer R. Rushton
Zachary D. Wallen
Sarabjot Pabla
Jeffrey M. Conroy
Mark Sausen

Frontiers in Oncology

doi 10.3389/fonc.2024.1445668

1,619 views

Editorial

Published on 31 Oct 2024

Editorial: Advances in the use of EGFR TKIs in the treatment of NSCLC

in Thoracic Oncology

Paola Ulivi

Frontiers in Oncology

doi 10.3389/fonc.2024.1506160

938 views